An analog of camptothecin inactive against Topoisomerase I is broadly neutralizing of HIV-1 through inhibition of Vif-dependent APOBEC3G degradation-Reference-Cited by-同舟云学术

An analog of camptothecin inactive against Topoisomerase I is broadly neutralizing of HIV-1 through inhibition of Vif-dependent APOBEC3G degradation

Published:2016-12 Issue: Volume:136 Page:51-59
ISSN:0166-3542
Container-title:Antiviral Research
language:en
Short-container-title:Antiviral Research

Author:

Bennett Ryan P.,Stewart Ryan A.,Hogan Priscilla A.,Ptak Roger G.,Mankowski Marie K.,Hartman Tracy L.,Buckheit Robert W.,Snyder Beth A.,Salter Jason D.,Morales Guillermo A.,Smith Harold C.

Funder

Public Health Service

Publisher

Elsevier BV

Subject

Virology,Pharmacology

Reference57 articles.

1. APOBEC3G is incorporated into virus-like particles by a direct interaction with HIV-1 Gag nucleocapsid protein;Alce;J. Biol. Chem.,2004

2. Transcriptional regulation of APOBEC3 antiviral immunity through the CBF-beta/RUNX axis;Anderson;Sci. Adv.,2015

3. Characterization of APOBEC3G binding to 7SL RNA;Bach;Retrovirology,2008

4. APOBEC3G impairs the multimerization of the HIV-1 Vif protein in living cells;Batisse;J. Virol.,2013

5. The SOCS-box of HIV-1 Vif interacts with ElonginBC by induced-folding to recruit its Cul5-containing ubiquitin ligase complex;Bergeron;PLoS Pathog.,2010

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of L15 as a novel Vif PROTAC degrader with antiviral activity against HIV-1;Bioorganic & Medicinal Chemistry Letters;2024-10

2. Quadruplex-duplex junction in LTR-III: A molecular insight into the complexes with BMH-21, namitecan and doxorubicin;PLOS ONE;2024-07-24

3. May I Help You with Your Coat? HIV-1 Capsid Uncoating and Reverse Transcription;International Journal of Molecular Sciences;2024-06-28

4. Design of Vif-Derived Peptide Inhibitors with Anti-HIV-1 Activity by Interrupting Vif-CBFβ Interaction;Viruses;2024-03-22

5. New latency-promoting agents for a block-and-lock functional cure strategy;Current Opinion in HIV and AIDS;2024-02-27